Form 8-K - Current report:
SEC Accession No. 0001213900-24-059660
Filing Date
2024-07-08
Accepted
2024-07-08 07:30:21
Documents
18
Period of Report
2024-07-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0208818-8k_virpax.htm   iXBRL 8-K 50723
2 FORM OF SECURED NOTE ea020881801ex4-1_virpax.htm EX-4.1 45008
3 SECURITIES PURCHASE AGREEMENT, DATED JULY 5, 2024, BY AND BETWEEN VIRPAX PHARMAC ea020881801ex10-1_virpax.htm EX-10.1 140491
4 SECURITY AGREEMENT, DATED JULY 5, 2024, BY AND BETWEEN VIRPAX PHARMACEUTICALS, I ea020881801ex10-2_virpax.htm EX-10.2 135380
5 PRESS RELEASE DATED JULY 8, 2024 ISSUED BY VIRPAX PHARMACEUTICALS, INC ea020881801ex99-1_virpax.htm EX-99.1 21509
6 GRAPHIC ex99-1_001.jpg GRAPHIC 8358
  Complete submission text file 0001213900-24-059660.txt   682539

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE vrpx-20240705.xsd EX-101.SCH 3027
8 XBRL LABEL FILE vrpx-20240705_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE vrpx-20240705_pre.xml EX-101.PRE 22367
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0208818-8k_virpax_htm.xml XML 3804
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

EIN.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40064 | Film No.: 241103362
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)